Carisma Therapeutics Files 8-K
Ticker: CARM · Form: 8-K · Filed: Jun 12, 2025 · CIK: 1485003
Sentiment: neutral
Topics: 8-K, disclosure
Related Tickers: CRIS
TL;DR
CRIS filed an 8-K, something happened on 6/10.
AI Summary
Carisma Therapeutics Inc. filed an 8-K on June 12, 2025, reporting an event that occurred on June 10, 2025. The filing is categorized under 'Other Events' and provides no specific details about the nature of the event in the provided text.
Why It Matters
This filing indicates a material event has occurred for Carisma Therapeutics Inc., requiring disclosure to investors.
Risk Assessment
Risk Level: low — The filing is a standard disclosure form with no immediate indication of negative financial or operational impact.
Key Players & Entities
- Carisma Therapeutics Inc. (company) — Registrant
- June 10, 2025 (date) — Earliest event reported date
- June 12, 2025 (date) — Date of report
- 3675 Market Street, Suite 401 Philadelphia, PA 19104 (address) — Principal Executive Offices
FAQ
What specific event is being reported under 'Other Events'?
The provided text of the 8-K filing does not specify the nature of the 'Other Events' that occurred on June 10, 2025.
When was the 8-K filing submitted to the SEC?
The 8-K filing was submitted on June 12, 2025.
What is the principal executive office address for Carisma Therapeutics Inc.?
The principal executive office is located at 3675 Market Street, Suite 401, Philadelphia, PA 19104.
What is the Commission File Number for Carisma Therapeutics Inc.?
The Commission File Number for Carisma Therapeutics Inc. is 001-36296.
What was the former name of Carisma Therapeutics Inc.?
Carisma Therapeutics Inc. was formerly known as Sesen Bio, Inc. and Eleven Biotherapeutics, Inc.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding Carisma Therapeutics Inc. (CARM).